BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38403587)

  • 21. Hypoxia Promotes Pancreatic Cancer Cell Dedifferentiation to Stem-Like Cell Phenotypes With High Tumorigenic Potential by the HIF-1α/Notch Signaling Pathway.
    Mu R; Zou YK; Tu K; Wang DB; Tang D; Yu Z; Zhao L
    Pancreas; 2021 May-Jun 01; 50(5):756-765. PubMed ID: 34016895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of chronic intermittent hypoxia-induced HIF-1α/ATAD2 expression on lung cancer stemness.
    Hao S; Li F; Jiang P; Gao J
    Cell Mol Biol Lett; 2022 Jun; 27(1):44. PubMed ID: 35672694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions.
    Liu M; Du K; Fu Z; Zhang S; Wu X
    Med Oncol; 2015 Jan; 32(1):394. PubMed ID: 25432699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scutellaria baicalensis targets the hypoxia-inducible factor-1α and enhances cisplatin efficacy in ovarian cancer.
    Hussain I; Waheed S; Ahmad KA; Pirog JE; Syed V
    J Cell Biochem; 2018 Sep; 119(9):7515-7524. PubMed ID: 29797601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma.
    Zhao M; Zhang Y; Zhang H; Wang S; Zhang M; Chen X; Wang H; Zeng G; Chen X; Liu G; Zhou C
    Lung Cancer; 2015 Feb; 87(2):98-106. PubMed ID: 25512094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition.
    Nan Y; Wu X; Luo Q; Chang W; Zhao P; Zhang L; Liu Z
    Proc Natl Acad Sci U S A; 2024 May; 121(19):e2315348121. PubMed ID: 38701117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer.
    Tang YA; Chen YF; Bao Y; Mahara S; Yatim SMJM; Oguz G; Lee PL; Feng M; Cai Y; Tan EY; Fong SS; Yang ZH; Lan P; Wu XJ; Yu Q
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5990-E5999. PubMed ID: 29891662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness.
    Raspaglio G; Petrillo M; Martinelli E; Li Puma DD; Mariani M; De Donato M; Filippetti F; Mozzetti S; Prislei S; Zannoni GF; Scambia G; Ferlini C
    Gene; 2014 Jun; 542(2):173-81. PubMed ID: 24661907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
    Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
    Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling.
    Jones RB; Dorsett KA; Hjelmeland AB; Bellis SL
    J Biol Chem; 2018 Apr; 293(15):5659-5667. PubMed ID: 29475939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromatin target of protein arginine methyltransferase regulates invasion, chemoresistance, and stemness in epithelial ovarian cancer.
    Feng X; Li L; Wang L; Luo S; Bai X
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1α (HIF-1α).
    Zhang L; Wu H; Zhang Y; Xiao X; Chu F; Zhang L
    Bioengineered; 2022 Jan; 13(1):950-962. PubMed ID: 34969360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer.
    Gomez-Roman N; Sahasrabudhe NM; McGregor F; Chalmers AJ; Cassidy J; Plumb J
    Oncotarget; 2016 Apr; 7(16):22650-64. PubMed ID: 26967059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIF Inactivation of p53 in Ovarian Cancer Can Be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity.
    Parmakhtiar B; Burger RA; Kim JH; Fruehauf JP
    Mol Cancer Res; 2019 Aug; 17(8):1675-1686. PubMed ID: 31088908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.
    Ghim J; Moon JS; Lee CS; Lee J; Song P; Lee A; Jang JH; Kim D; Yoon JH; Koh YJ; Chelakkot C; Kang BJ; Kim JM; Kim KL; Yang YR; Kim Y; Kim SH; Hwang D; Suh PG; Koh GY; Kong YY; Ryu SH
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1697-703. PubMed ID: 24947526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of NRF2 with HIF-2α-induced cancer stem cell phenotypes in chronic hypoxic condition.
    Hallis SP; Kim SK; Lee JH; Kwak MK
    Redox Biol; 2023 Apr; 60():102632. PubMed ID: 36791645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neil 1 deficiency facilitates chemoresistance through upregulation of RAD18 expression in ovarian cancer stem cells.
    Shukla D; Mandal T; Srivastava AK
    Biochem Biophys Res Commun; 2024 Jun; 712-713():149907. PubMed ID: 38636303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.